| Literature DB >> 31358803 |
Yosi Nindita1,2, Zhisheng Cao1, Amirudin Akhmad Fauzi1, Aiko Teshima1, Yuya Misaki1,2, Rukman Muslimin1, Yingjie Yang1, Yuh Shiwa3, Hirofumi Yoshikawa3,4, Michihira Tagami5, Alexander Lezhava5, Jun Ishikawa6, Makoto Kuroda7, Tsuyoshi Sekizuka7, Kuninobu Inada8, Haruyasu Kinashi1, Kenji Arakawa9,10.
Abstract
Streptomyces rochei 7434AN4 produces two structurally unrelated polyketide antibiotics, lankacidin and lankamycin, and carries three linear plasmids, pSLA2-L (211 kb), -M (113 kb), and -S (18 kb), whose nucleotide sequences were previously reported. The complete nucleotide sequence of the S. rochei chromosome has now been determined using the long-read PacBio RS-II sequencing together with short-read Illumina Genome Analyzer IIx sequencing and Roche 454 pyrosequencing techniques. The assembled sequence revealed an 8,364,802-bp linear chromosome with a high G + C content of 71.7% and 7,568 protein-coding ORFs. Thus, the gross genome size of S. rochei 7434AN4 was confirmed to be 8,706,406 bp including the three linear plasmids. Consistent with our previous study, a tap-tpg gene pair, which is essential for the maintenance of a linear topology of Streptomyces genomes, was not found on the chromosome. Remarkably, the S. rochei chromosome contains seven ribosomal RNA (rrn) operons (16S-23S-5S), although Streptomyces species generally contain six rrn operons. Based on 2ndFind and antiSMASH platforms, the S. rochei chromosome harbors at least 35 secondary metabolite biosynthetic gene clusters, including those for the 28-membered polyene macrolide pentamycin and the azoxyalkene compound KA57-A.Entities:
Mesh:
Year: 2019 PMID: 31358803 PMCID: PMC6662830 DOI: 10.1038/s41598-019-47406-y
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
General features of the chromosomes of Streptomyces rochei 7434AN4 and five other Streptomyces species.
| Speciesa | Length (bp) | G + C content (%) | CDS (no.) | Average CDS length (bp) | TIR (bp) | rRNAs (no.) | tRNA (no.) |
|---|---|---|---|---|---|---|---|
| 8,364,802 | 71.7 | 7,568 | 973 | 53,892 | 7 | 67 | |
| 8,667,507 | 72.1 | 7,825 | 991 | 21,653 | 6 | 63 | |
| 9,025,608 | 70.7 | 7,582 | 1,027 | 49 | 6 | 68 | |
| 8,545,929 | 72.2 | 7,138 | 1,055 | 132,910 | 6 | 66 | |
| 10,145,833 | 71.9 | 8,849 | 952 | 14 | 6 | 68 | |
| 10,148,695 | 71.5 | 8,746 | 1,005 | 18,488 | 6 | 75 |
aGenBank accession number: S. rochei 7434AN4 chromosome, AP018517; S. coelicolor A3(2), NC_003888; S. avermitilis MA-4680, NC_003155; S. griseus IFO13350, NC_010572; S. hygroscopicus 5008, CP003275; S. scabies 87.22, NC_013929.
Figure 1Secondary metabolites produced by Streptomyce rochei 7434AN4 and its mutants. Polyketide antibiotics; lankacidin C and lankamycin. Signaling molecules; SRB1 and SRB2. Azoxyalkene; KA57-A. Polyketides; citreodiol, epi-citreodiol, and pentamycin.
General features of the chromosome and three plasmids of S. rochei 7434AN4.
| Repliconsa | Length (bp) | G + C content (%) | CDS (no.) | Average CDS length (bp) | TIR (bp) |
|---|---|---|---|---|---|
| Chromosome | 8,364,802 | 71.7 | 7,568 | 973 | 53,892 |
| pSLA2-L | 210,614 | 72.8 | 143 | 1,330 | 1,992 |
| pSLA2-M | 113,464 | 69.7 | 121 | 718 | 352 |
| pSLA2-S | 17,526 | 69.7 | 22 | 508 | 817 |
aGenBank accession number: S. rochei 7434AN4 chromosome, AP018517; pSLA2-L, AB088224; pSLA2-M, AB597522; pSLA2-S, AB905437.
Figure 2Schematic representation of the S. rochei chromosome. Scale bars are drawn in megabases. (i) AseI physical map. The possible core region of the S. rochei chromosome (1.31–6.80 Mb) is marked as yellow. (ii) Distribution of rRNA-encoding gene (rDNA) operons and eight assembled contigs. Gray and blue arrows are 5S-23S rDNA operon, while red is 16S rDNA. (iii) Distribution of tRNAs. (iv) Distribution of secondary metabolite gene clusters. (v) Distribution of CDSs according to direction of transcription (+ strand, upper line; − strand, lower line). (vi) GC-skew for 10-kb window and 500-bp step. The putative oriC (gene) locus is indicated by a blue arrow. Main features were generated by DNA plotter software (https://www.sanger.ac.uk/science/tools/dnaplotter)[15].
Figure 3Terminal inverted repeat (TIR) of the S. rochei chromosome. (a) Nucleotide sequence comparison of inside ends of the TIR regions. Identical sequences are indicated by asterisks. Ch-L, chromosome left region; Ch-R, chromosome right region. (b) Southern hybridization analysis of the TIR regions. PCR fragment harboring nt 52,079–55,053 was used as a DNA probe to distinguish the TIR boundary. λ-DNA digested with HindIII was used as a DNA size marker. Lane M, λ/HindIII marker; lane 1, S. rochei 7434AN4 total DNA digested with BamHI; lane 2, S. rochei 7434AN4 total DNA digested with XhoI. (c) Restriction map of the left and right TIR regions of the S. rochei 7434AN4 chromosome. TIR regions of the chromosome are shown by thick black lines. Terminal proteins attached to the 5′-ends are indicated by filled circles. Some important restriction sites are indicated. Bg, BglII; Ba, BamHI; Xh, XhoI; Ec, EcoRI; Kp, KpnI.
Figure 4Venn diagram of the number of shared and unique genes between S. rochei and four other Streptomyces strains. OrthoVenn, a web-based application (http://www.bioinfogenome.net/OrthoVenn/) was used in this analysis. Other Streptomyces strains used in this analysis are S. coelicolor A3(2), S. avermitilis MA-4680, S. griseus IFO13350, and S. hygroscopicus 5008.
List of secondary metabolite biosynthetic gene clusters in the S. rochei chromosome.
| Clustera | Product type | Location | Length (bp) | Possible metabolites |
|---|---|---|---|---|
| 1 | PKS-NRPS | SRO_0155-SRO_0157 | 12,171 | |
| 2 | Siderophore | SRO_0365-SRO_0370 | 8,474 | |
| 3 | Terpene | SRO_0471-SRO_0472 | 2,153 | 2-Methylisoborneol |
| 4 | PKS-NRPS | SRO_0501-SRO_0517 | 49,191 | |
| 5 | PKS | SRO_0730-SRO_0739 | 15,137 | |
| 6 | Lantipeptide-NRPS | SRO_0832-SRO_0848 | 34,433 | |
| 7 | PKS-NRPS | SRO_1003-SRO_1008 | 13,813 | |
| 8 | NRPS-Lantipeptide | SRO_1184-SRO_1189 | 11,055 | |
| 9 | Terpene | SRO_1200-SRO_1204 | 6,711 | Hopene |
| 10 | NRPS | SRO_1300-SRO_1346 | 70,044 | |
| 11 | NRPS | SRO_1551-SRO_1557 | 21,989 | |
| 12 | PKS-NRPS | SRO_1613-SRO_1615 | 11,979 | |
| 13 | Terpene | SRO_1735-SRO_1737 | 4,337 | Geosmin |
| 14 | Azoxyalkene and type I PKS | SRO_1819-SRO_1850 | 36,010 | KA57-A |
| 15 | Siderophore | SRO_2036-SRO_2038 | 4,744 | |
| 16 | NRPS | SRO_2051-SRO_2053 | 5,458 | |
| 17 | NRPS | SRO_2500-SRO_2506 | 9,881 | |
| 18 | Terpene | SRO_2585-SRO_2586 | 2,410 | Albaflavenone |
| 19 | Butyrolactone | SRO_3382 | 932 | |
| 20 | NRPS-Lantipeptide | SRO_3845-SRO_3849 | 6,875 | |
| 21 | Type II PKS | SRO_4037-SRO_4044 | 7,077 | Spore pigment |
| 22 | Siderophore | SRO_4684-SRO_4688 | 5,997 | |
| 23 | Melanin | SRO_4761-SRO_4762 | 1,446 | Melanin |
| 24 | Ectoine | SRO_5592-SRO_5595 | 3,165 | 5-Hydroxyectoine |
| 25 | Type I PKS | SRO_6166-SRO_6168 | 12,248 | |
| 26 | Type III PKS | SRO_6250-SRO_6251 | 2,284 | |
| 27 | NRPS | SRO_6287-SRO_6291 | 9,037 | |
| 28 | NRPS | SRO_6304-SRO_6312 | 46,390 | |
| 29 | Type I PKS (Iterative) | SRO_6377-SRO_6381 | 12,789 | |
| 30 | Pseudosugar | SRO_6636-SRO_6646 | 12,173 | |
| 31 | NRPS | SRO_7209-SRO_7215 | 44,813 | |
| 32 | Type I PKS | SRO_7221-SRO_7235 | 81,482 | Pentamycin |
| 33 | Type I PKS (Iterative) | SRO_7329-SRO_7331 | 9,456 | |
| 34 | NRPS | SRO_7379-SRO_7381 | 3,029 | |
| 35 | Terpene | SRO_7452-SRO_7458 | 8,979 | Carotenoid |
aSecondary metabolite gene clusters were predicted by 2nd Find and antiSMASH. The range of gene clusters for unknown secondary metabolites was estimated on the basis of putative functions of gene products.
Figure 5Morphological differentiation of three plasmidless mutants of S. rochei and their chromosomal deletion. (a) Spore formation of S. rochei strains. Strains (2-39, YN-P7, YN-P145, and their parent 51252) were grown on YM agar medium at 28 °C for 5 days. (b) Scanning electron microscopy (SEM) of surface grown colonies. (c) Chromosomal deletions in mutants 2-39, YN-P7, and YN-P145.